إعلان
إعلان

SLXN

SLXN logo

Silexion Therapeutics Corp Ordinary Shares

2.13
USD
برعاية
+0.02
+1.19%
٠٨ يناير, ١٥:٥٢ UTC -5
مغلق
exchange

بعد الإغلاق

2.11

-0.01
-0.66%

تقارير أرباح SLXN

النسبة الإيجابية المفاجئة

SLXN تفوق 2 من 5 آخر التقديرات.

40%

التقرير التالي

بيانات التقرير القادم
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q-- -1 (Revenue/ EPS)
--
/
--

Silexion Therapeutics Corp Ordinary Shares earnings per share and revenue

On ١٢ نوفمبر ٢٠٢٥, SLXN reported earnings of -2.88 USD per share (EPS) for Q3 25, beating the estimate of -3.46 USD, resulting in a 16.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.56% price change (close before vs. close after earnings).
Looking ahead to -- --, -- المحللين forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Silexion Therapeutics Corp Ordinary Shares reported EPS of -$2.88, beating estimates by 16.96%, and revenue of $0.00, 0% as expectations.
The stock price moved up 3.56%, changed from $2.81 before the earnings release to $2.91 the day after.
The next earning report is scheduled for --.
Based on -- المحللين, Silexion Therapeutics Corp Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان